Renovaro Biosciences Inc. (RENB)
undefined
undefined%
At close: undefined
1.71
-3.39%
After-hours Dec 13, 2024, 06:08 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income -80.65M -39.68M -113.43M -26.72M -11.42M -18.02M -6.31M -2.14M -1.74M
Depreciation & Amortization 121.86K 113.50K 123.59K 123.53K 366.27K 71.71K 18.48K 14.53K 27.39K
Stock-Based Compensation 4.67M 3.54M 5.49M 1.44M 1.03M - - - -
Other Working Capital 4.75M 410.16K 332.21K 1.20M -175.59K 109.00K -311.04K 127.18K -78.48K
Other Non-Cash Items 56.07M 995.80K -2.60M 3.34M -200.59K 9.29M 1.85M 1.21M -254.54K
Deferred Income Tax - - - - - - - - -
Change in Working Capital 8.81M 4.31M 1.42M 1.20M -97.47K 198.88K -83.46K -53.96K 233.20K
Operating Cash Flow -10.97M -11.77M -15.73M -20.61M -10.46M -8.51M -4.34M -1.18M -1.47M
Capital Expenditures -70.43K -29.77K -5.16K -48.89K -184.46K -716.67K -30.00K - -
Acquisitions 65.85K - - - - - -294.93K - -
Purchase of Investments - - - - - - - - -
Sales Maturities Of Investments - - - - - - - - -
Other Investing Acitivies -1.26M - - - - - -250.80K -196.14K -
Investing Cash Flow -1.26M -29.77K -5.16K -48.89K -184.46K -716.67K -575.73K -196.14K -
Debt Repayment 7.18M -1.12M -560.85K -546.65K 6.20M - - 2.00M -
Common Stock Repurchased - - - - - - - - -
Dividend Paid - - - - - - - - -
Other Financial Acitivies 341.87K 1.63M 134.91K 82.06K 1.00M 6.02M - - -
Financial Cash Flow 10.52M 4.52M 4.25M 32.60M 7.20M 6.02M 16.71M 5.51M -
Net Cash Flow -1.65M -7.30M -11.49M 11.97M -3.59M -3.32M 11.66M 3.92M -1.47M
Free Cash Flow -11.04M -11.80M -15.74M -20.66M -10.64M -9.22M -4.37M -1.18M -1.47M